Clinical laboratory

How mRNA Vaccination May Affect the Progression of Chronic Kidney Disease

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

This study aimed to investigate whether mRNA and inactivated COVID-19 vaccines may accelerate the progression of chronic kidney disease (CKD).

  • mRNA vaccines induce more pronounced immune responses compared to classical vaccines.
  • The investigation focuses on the potential impact of COVID-19 vaccines on CKD progression.
  • Chronic kidney disease (CKD) is a significant health concern that may be influenced by vaccination.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the mrna technology brief

issue #59
A tweaked LNP formula cut liver accumulation while keeping local delivery intact
5 days ago7 studies
issue #58
Your gut microbiome may predict whether you'll get a fever after an mRNA vaccine
1 week ago7 studies
issue #57
AI found a thermostable mRNA vaccine formula in one month that survives 37°C for two months
2 weeks ago7 studies
issue #56
A microfluidics trick reorganized mRNA nanoparticles and cut tumor growth by 89% in mice
3 weeks ago7 studies
issue #55
An mRNA drug wiped out B cells in 3 patients with an autoimmune blood disorder — without cytokine release syndrome
4 weeks ago7 studies
issue #54
New 'charge-switching' lipid nanoparticles deliver RNA without triggering inflammation
5 weeks ago7 studies
issue #53
A cold-adapted viral enzyme makes cleaner mRNA with almost no inflammatory byproduct
6 weeks ago7 studies
issue #52
An mRNA treatment restored liver protein and improved disease markers in mice
7 weeks ago7 studies
issue #51
A synchronized STING vaccine suppressed tumor growth without triggering systemic immune chaos
8 weeks ago7 studies
issue #50
New LNPs crossed the blood-brain barrier in primates and cut stroke damage in rats
9 weeks ago7 studies
explore the archive
See more issues from the mrna technology brief